北美抗体发现市场预测至 2030 年 - 区域分析 - 按抗体类型(单克隆抗体、多克隆抗体及其他)、性质(人类和人源化、嵌合和鼠类)、服务(噬菌体展示、杂交瘤、转基因动物、单细胞和酵母展示)和最终用户(制药和生物技术公司、研究实验室及其他)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 94    |    Report Code: BMIRE00030774    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Antibody Discovery Market
2022 年,北美抗体发现市场价值为 12982.3757 亿美元,预计到 2030 年将达到 22016.9241 亿美元;预计 2022 年至 2030 年的复合年增长率为 6.8%。

增加研发投资推动北美抗体发现市场

抗体(包括单克隆抗体和多克隆抗体)可应用于学术、研究和制药机构和组织,其中它们用于与药物和生物标志物开发以及其他治疗和临床诊断产品开发相关的多项研发活动。中小型公司每年都专注于增加研发投资。 2020 年 4 月,美国联邦政府根据《冠状病毒援助、救济和经济安全 (CARES) 法案》向生物医学高级研究与发展局 (BARDA) 拨款 35 亿美元,为疫苗、诊断、治疗和小分子活性药物成分 (API) 等的制造、生产和采购提供资金支持。此外,制药公司 Bio-Rad 提供 10,000 种抗体以及抗原、试剂和缓冲液,用于开发体外诊断测试。因此,制药公司在与抗体发现相关的研发活动方面的投资不断增加,以开发针对各种疾病的更好治疗方案,推动了抗体发现市场的增长。

北美抗体发现市场概览

北美抗体发现市场分为美国、加拿大和墨西哥。该地区的市场增长取决于癌症患病率的增加、抗体研究行业的强大存在以及研发领域的技术进步。根据美国癌症协会的数据,2020 年美国诊断出约 180 万例新癌症病例,约 606,520 例癌症相关死亡病例。这增加了对治疗性抗体的需求,从而推动了抗体发现市场的增长。资金的激增进一步推动了新技术的开发、跨国家和组织汇集资源和专业知识以及对现有抗体治疗方法进行研究。这使人们更好地了解了免疫系统,并开发了有效和有针对性的抗体。此外,增加的资金使科学家能够进行大规模临床试验,这些试验对于评估特定抗体的有效性是必不可少的。

北美抗体发现市场收入和预测到 2030 年(十亿美元)

北美抗体发现市场细分

北美抗体发现市场分为抗体类型、性质、服务、最终用户和国家。

根据抗体类型,北美抗体发现市场细分为单克隆抗体、多克隆抗体和其他。单克隆抗体部分在 2022 年占据了北美抗体发现市场的最大份额。

就性质而言,北美抗体发现市场细分为人类和人源化、嵌合和鼠类。人类和人源化部分在 2022 年占据了北美抗体发现市场的最大份额。

按服务,北美抗体发现市场分为噬菌体展示、杂交瘤、转基因动物、单细胞和酵母展示。噬菌体展示部分在 2022 年占据了北美抗体发现市场的最大份额。

根据最终用户,北美抗体发现市场分为制药和生物技术公司、研究实验室等。 2022 年,制药和生物技术公司部门占据了北美抗体发现市场的最大份额。

根据国家/地区,北美抗体发现市场分为美国、加拿大和墨西哥。2022 年,美国占据了北美抗体发现市场份额的主导地位。

Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Bruker Cellular Analysis Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、NanoCellect Biomedical Inc 和 Biocytogen Pharmaceuticals Beijing Co Ltd. 是北美抗体发现市场的一些领先公司。

North America Antibody Discovery Strategic Insights

Strategic insights for North America Antibody Discovery involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-antibody-discovery-market-strategic-framework.webp
Get more information on this report

North America Antibody Discovery Report Scope

Report Attribute Details
Market size in 2022 US$ 12,98,237.57 Million
Market Size by 2030 US$ 22,01,692.41 Million
Global CAGR (2022 - 2030) 6.8%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 抗体类型
  • 单克隆抗体
  • 多克隆抗体
By 自然
  • 人类和人源化
  • 嵌合
  • é¼ ç±»
By 最终用户
  • 制药和生物技术公司
  • 研究实验室
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Bruker Cellular Analysis Inc
  • BioDuro LLC
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • NanoCellect Biomedical Inc
  • Biocytogen Pharmaceuticals Beijing Co Ltd
  • Get more information on this report

    North America Antibody Discovery Regional Insights

    The regional scope of North America Antibody Discovery refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-antibody-discovery-market-geography.webp
    Get more information on this report

    The List of Companies - North America Antibody Discovery Market

    1. Charles River Laboratories International Inc
    2. Creative Biolabs Inc
    3. Evotec SE
    4. Bruker Cellular Analysis Inc
    5. BioDuro LLC
    6. Sartorius AG
    7. Aragen Life Sciences Ltd
    8. Twist Bioscience Corp
    9. NanoCellect Biomedical Inc
    10. Biocytogen Pharmaceuticals Beijing Co Ltd
    Frequently Asked Questions
    How big is the North America Antibody Discovery Market?

    The North America Antibody Discovery Market is valued at US$ 12,98,237.57 Million in 2022, it is projected to reach US$ 22,01,692.41 Million by 2030.

    What is the CAGR for North America Antibody Discovery Market by (2022 - 2030)?

    As per our report North America Antibody Discovery Market, the market size is valued at US$ 12,98,237.57 Million in 2022, projecting it to reach US$ 22,01,692.41 Million by 2030. This translates to a CAGR of approximately 6.8% during the forecast period.

    What segments are covered in this report?

    The North America Antibody Discovery Market report typically cover these key segments-

  • 抗体类型 (单克隆抗体, 多克隆抗体)
  • 自然 (人类和人源化, 嵌合, 鼠类)
  • 最终用户 (制药和生物技术公司, 研究实验室)
  • What is the historic period, base year, and forecast period taken for North America Antibody Discovery Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Antibody Discovery Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in North America Antibody Discovery Market?

    The North America Antibody Discovery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Bruker Cellular Analysis Inc
  • BioDuro LLC
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • NanoCellect Biomedical Inc
  • Biocytogen Pharmaceuticals Beijing Co Ltd
  • Who should buy this report?

    The North America Antibody Discovery Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Antibody Discovery Market value chain can benefit from the information contained in a comprehensive market report.